Quintiles Rejects Buy-Out Offer From Founder Gillings, Weighs Options
Executive Summary
Quintiles will look for potential buyers after rejecting an acquisition offer from founder and Chairman Dennis Gillings, PhD
You may also be interested in...
Quintiles going private
Quintiles accepts bid from Chairman Dennis Gillings, PhD, to buy company for $14.50/share. Agreement represents $3.25/share increase over Gillings' original proposal (1"The Pink Sheet" Nov. 18, 2002, p. 9)...
Quintiles going private
Quintiles accepts bid from Chairman Dennis Gillings, PhD, to buy company for $14.50/share. Agreement represents $3.25/share increase over Gillings' original proposal (1"The Pink Sheet" Nov. 18, 2002, p. 9)...
Lilly Dual-Acting Cymbalta Promoted By Dual Sales Force With Quintiles Deal
Lilly's use of a dual sales force for the antidepressant Cymbalta follows the Evista model